对抗非小细胞肺癌的运动:新的见解
Abel Plaza-Florido1, Carmen Fiuza-Luces2, Alejandro Lucia3
1Pediatric Exercise and Genomics Research Center, Department of Pediatrics, School of Medicine, University of California Irvine, Irvine, CA, USA.
Trends in cancer
|December 5, 2024
概括
运动可以通过像miR-29a-3p这样的肌肉衍生微RNA (miRNA) 来对抗非小细胞肺癌 (NSCLC). 这些分子通过细胞外囊泡 (EV) 传递,可以抑制瘤生长并增强抗癌免疫力.
科学领域:
- 运动生理学 运动生理学
- 分子瘤学分子瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 运动的抗癌作用尚未完全理解.
- 运动可以通过分子信号通路影响癌症的进展.
研究的目的:
- 确定参与打击非小细胞肺癌 (NSCLC) 的运动诱导分子.
- 研究肌肉衍生的细胞外囊泡 (EVs) 和相关的微RNA (miRNAs) 在运动的抗NSCLC作用中的作用.
主要方法:
- 肌肉衍生电动汽车及其货物的识别.
- 分析与NSCLC相关的特定微RNA (miR-29a-3p) 表达和功能.
- 评估细胞外矩阵 (ECM) 重塑和免疫细胞活性.
主要成果:
- 运动会诱导肌肉衍生的携带miR-29a-3p的EV.
- miR-29a-3p与抑制瘤细胞外基质 (ECM) 沉积有关.
- 与运动相关的miR-29a-3p增强了抗瘤免疫反应.
结论:
- 肌肉衍生的miR-29a-3p,由EVs运输,是运动潜在的抗NSCLC益处的关键调解者.
- 这一途径涉及调节瘤微环境和免疫监测.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
9.6K
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
